Principal investigator: Emily Huang, DO
Co-Principal investigator: William McKinley, MD
Purpose: To observe spasticity in a previously untreated population with cerebral palsy, assess the contributions of age, diagnosis, distribution of muscle involvement and monitor functional abilities pre and post intervention with botulism toxin-A.
Principal Investigator: Beth Sasso PT
Co-investigators: Ashley Barrow OT, William McKinley, MD
Purpose: Commonwealth Neurotrauma Initiative (CNI) grant
providing state-of-the-art functional electrical stimulation (
More information:
Beth Sasso, PT
Phone: (804) 828-3170
Email:
Principal Investigator: Beth Sasso, PT
Co-investigator: William McKinley, MD
Purpose: Commonwealth Neurotrauma Initiative (CNI) grant
providing state-of-the-art functional electrical stimulation (
More information:
Beth Sasso, PT
Phone: (804) 828-3170
Email:
Principal investigator: William McKinley, MD
Purpose: To review and analyze the incidence and prognostic factors related to secondary medical complications in individuals with non-traumatic SCI
More information:
William McKinley, MD
Phone: (804) 828-4233
Email:
Principal investigator: William McKinley, MD
Purpose: To review and analyze the incidence and prognostic factors related to secondary medical complications in individuals with non-traumatic SCI
More information:
William McKinley, MD
Phone: (804) 828-4233
Email:
Principal investigator: William McKinley, MD
Co-investigator: John Gibbs, MD
Purpose: To compare injury characteristics, demographics, and functional outcomes of patients with vascular-related spinal cord disease to those with traumatic SCI.
More information:
William McKinley, MD
Phone: (804) 828-4233
Email:
Principal investigator: Greg Stockslager, PT
Co-Principal investigator: William McKinley, MD
Purpose: To evaluate the efficacy of locomotor treadmill training on functional and neurological recovery after SCI
More information:
William McKinley, MD
Phone: (804) 828-4233
Email:
Site investigator: William McKinley, MD
Study Coordinator: Michelle Meade, PhD
Purpose: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial of Pregabalin for the Treatment of Chronic Neuropathic Pain after SCI
More information:
William McKinley, MD
Phone: (804) 828-4233
Email:wmckinley@mcvh-vcu.edu

Virginia Commonwealth University | School of Medicine | Department of Physical Medicine and Rebabilitation
Department Contact information | This Site Maintained by: Wade Broussard
Last updated: 5/15/2008